Diabetes insipidus and SIADH: Pathology review

Last updated: December 08, 2021

Diabetes insipidus and SIADH: Pathology review

Watch later

Watch later

Sepsis
Infective endocarditis: Clinical
Endocarditis: Pathology review
Endocarditis
Fever of unknown origin: Clinical
Salmonella typhi (typhoid fever)
Plasmodium species (Malaria)
Schistosomes
Zinc deficiency and protein-energy malnutrition: Pathology review
Hypophosphatemia
Hyponatremia
Hyponatremia: Clinical
Hypertriglyceridemia
Hypertensive disorders of pregnancy: Clinical
Preeclampsia & eclampsia
Gestational hypertension
Gestational diabetes
Contraception: Clinical
Preterm labor
Erectile dysfunction
PDE5 inhibitors
Fallopian tube and uterus histology
Endometriosis
Chlamydia trachomatis
Neisseria gonorrhoeae
Treponema pallidum (Syphilis)
Congenital syphilis
Sexually transmitted infections: Clinical
HIV (AIDS)
Herpes simplex virus
Human papillomavirus
Endometrial hyperplasia
Endometrial cancer
Endometrial hyperplasia and cancer: Clinical
Ovarian cysts and tumors: Pathology review
Cervical cancer
Cervical cancer: Clinical
Cervical cancer: Pathology review
Ectopic pregnancy
Endometritis
Pelvic inflammatory disease
Ovarian germ cell tumors
Ovarian cysts, cancer, and other adnexal masses: Clinical
Sexual dysfunctions: Clinical
Anatomy clinical correlates: Wrist and hand
Placenta previa
Placental abruption
Vaginal versus cesarean delivery: Clinical
Antepartum hemorrhage: Clinical
Postpartum hemorrhage
Postpartum hemorrhage: Clinical
Urinary incontinence
Stages of labor
Shock
Shock: Clinical
Shock: Pathology review
Opioid agonists, mixed agonist-antagonists and partial agonists
Opioid use disorder
Opioid antagonists
Syncope: Clinical
Hypertension: Clinical
Hypertension
Hypertension: Pathology review
Local anesthetics
Ventricular arrhythmias: Pathology review
Supraventricular arrhythmias: Pathology review
Wolff-Parkinson-White syndrome
Ventricular fibrillation
Class II antiarrhythmics: Beta blockers
Class III antiarrhythmics: Potassium channel blockers
Class IV antiarrhythmics: Calcium channel blockers and others
Atrial fibrillation
Atrial flutter
Ventricular tachycardia
Premature ventricular contraction
Heart failure
Heart failure: Pathology review
Heart failure: Clinical
Nephrotic syndromes: Pathology review
Nephritic and nephrotic syndromes: Clinical
Nephritic syndromes: Pathology review
Frank-Starling relationship
Aortic dissection
Aortic dissections and aneurysms: Pathology review
Aortic aneurysms and dissections: Clinical
Pericarditis and pericardial effusion
Atherosclerosis and arteriosclerosis: Pathology review
Angina pectoris
Leg ulcers: Clinical
Chronic venous insufficiency
Ischemic stroke
Stroke: Clinical
ECG cardiac hypertrophy and enlargement
Hypertrophic cardiomyopathy
Cardiomyopathies: Pathology review
Cardiomyopathies: Clinical
Dilated cardiomyopathy
Restrictive cardiomyopathy
Long QT syndrome and Torsade de pointes
Brugada syndrome
Action potentials in pacemaker cells
Asthma
Asthma: Clinical
Pneumonia
Pneumonia: Clinical
Pneumonia: Pathology review
Streptococcus pneumoniae
Pneumocystis jirovecii (Pneumocystis pneumonia)
Reading a chest X-ray
Mycobacterium tuberculosis (Tuberculosis)
Tuberculosis: Pathology review
Upper respiratory tract infection
General anesthetics
Lung cancer
Lung cancer: Clinical
Lung cancer and mesothelioma: Pathology review
Chronic obstructive pulmonary disease (COPD): Clinical
Sleep apnea
Apnea, hypoventilation and pulmonary hypertension: Pathology review
Sleep disorders: Clinical
Sleep
Narcolepsy (NORD)
Clinical Skills: BiPAP and CPAP
Restrictive lung diseases
Restrictive lung diseases: Pathology review
Diffuse parenchymal lung disease: Clinical
Idiopathic pulmonary fibrosis
Hypersensitivity pneumonitis
Sarcoidosis
Acetaminophen (Paracetamol)
Paracetamol toxicity
Non-steroidal anti-inflammatory drugs
Respiratory alkalosis
Metabolic and respiratory alkalosis: Clinical
Metabolic and respiratory acidosis: Clinical
Advanced cardiac life support (ACLS): Clinical
Respiratory acidosis
Pancoast tumor
Congenital cytomegalovirus (NORD)
Congenital TORCH infections: Pathology review
Alport syndrome
Pediatric ear, nose, and throat conditions: Clinical
Turner syndrome
Down syndrome (Trisomy 21)
Developmental milestones: Clinical
Neonatal sepsis
Auditory transduction and pathways
Muscular dystrophy
Cerebral palsy
Respiratory syncytial virus
Respiratory distress syndrome: Pathology review
Newborn management: Clinical
Neonatal respiratory distress syndrome
Appendicitis
Appendicitis: Clinical
Appendicitis: Pathology review
Meckel diverticulum
Neonatal jaundice: Clinical
Hirschsprung disease
Congenital gastrointestinal disorders: Pathology review
Pediatric allergies: Clinical
Pediatric constipation: Clinical
Pediatric vomiting: Clinical
Febrile seizure
Rotator cuff tear
Carpal tunnel syndrome
Achilles tendon rupture
Patellar tendon rupture
Anterior cruciate ligament injury
Spinal disc herniation
Sciatica
Degenerative disc disease
Compartment syndrome
Osteomyelitis
Bone tumors
Osteoporosis
Osteomalacia and rickets
Osteoarthritis
Rheumatoid arthritis
Gout
Psoriatic arthritis
Ankylosing spondylitis
Septic arthritis
Bursitis
Polymyositis
Dermatomyositis
Myasthenia gravis
Lambert-Eaton myasthenic syndrome
Sjogren syndrome
Systemic lupus erythematosus
Raynaud phenomenon
Platelet plug formation (primary hemostasis)
Coagulation (secondary hemostasis)
Role of Vitamin K in coagulation
Clot retraction and fibrinolysis
Anticoagulants: Heparin
Anticoagulants: Warfarin
Anticoagulants: Direct factor inhibitors
Sensitivity and specificity
Positive and negative predictive value
Sickle cell disease (NORD)
Sickle cell disease: Clinical
Cystic fibrosis
Cystic fibrosis: Pathology review
Cystic fibrosis: Clinical
Phenylketonuria (NORD)
Non-corticosteroid immunosuppressants and immunotherapies
Glucocorticoids
Child abuse: Clinical
Abdominal hernias
Hernias: Clinical
Inguinal hernia
Femoral hernia
Volvulus
Varicocele
Nutcracker syndrome
Testicular tumors: Pathology review
Testicular torsion
Intestinal atresia
Tracheoesophageal fistula
Necrotizing enterocolitis
Diabetes mellitus
Diabetes mellitus: Clinical
Diabetes mellitus: Pathology review
Gestational diabetes
Hypoglycemics: Insulin secretagogues
Insulins
Diabetic nephropathy
Diabetic retinopathy
Diabetes insipidus
Insulin
Diabetes insipidus and SIADH: Pathology review
Pituitary gland histology
Anatomy of the thyroid and parathyroid glands
Thyroid and parathyroid gland histology
Pituitary tumors: Pathology review
Pituitary adenomas and pituitary hyperfunction: Clinical
Pituitary adenoma
Hyperprolactinemia
Prolactinoma
Cushing syndrome
Cushing syndrome: Clinical
Cushing syndrome and Cushing disease: Pathology review
Acromegaly
Gigantism
Hypopituitarism
Hypopituitarism: Clinical
Hypopituitarism: Pathology review
Hyperpituitarism
Pituitary apoplexy
Adrenal gland histology
Primary adrenal insufficiency
Adrenal insufficiency: Clinical
Adrenal insufficiency: Pathology review
Thyroid nodules and thyroid cancer: Clinical
Thyroid nodules and thyroid cancer: Pathology review
Thyroid cancer
Hashimoto thyroiditis
Thyroid storm
Thyroid hormones
Hypothyroidism and thyroiditis: Clinical
Hyperthyroidism
Hyperthyroidism: Pathology review
Hyperthyroidism: Clinical
Hyperthyroidism medications
Hypothyroidism
Hypothyroidism medications
Hypothyroidism: Pathology review
Toxic multinodular goiter
Graves disease
Cortisol
Renin-angiotensin-aldosterone system
Conn syndrome
Waterhouse-Friderichsen syndrome
Adrenal masses and tumors: Clinical
Adrenal masses: Pathology review
Skin cancer
Skin cancer: Pathology review
Skin cancer: Clinical
Sarcoptes scabiei (Scabies)
Anti-mite and louse medications
Psoriasis
Psoriatic arthritis
Eczematous rashes: Clinical
Atopic dermatitis
Contact dermatitis
Seborrhoeic dermatitis
Keratitis
Miscellaneous antifungal medications
Azoles

Transcript

Watch video only

Okay, so two people were admitted to the Endocrinology ward. One of them is 35 year old Imre, who came in with intense polyuria and polydipsia. Imre was dehydrated and presented with dry mouth, headache, dry skin and dizziness. Several tests were done and results showed increased serum osmolality and further on, a desmopressin test was done. During the test, an ADH analogue was administered and urine osmolality increased. The other person is 45 year old Sienna who came in to do some routine tests because she started taking cyclophosphamide and wanted to make sure that there are no complications. Her lab results showed hyponatremia, decreased blood osmolality, and her urine osmolality was higher than serum osmolality.

Now, both individuals are unable to maintain normal osmolality. But to understand this we need to go over a bit of physiology first. In the brain, specifically in the hypothalamus, there are osmoreceptors which can sense the osmolality of the blood, or how concentrated it is. Osmolality is the concentration of dissolved particles in the blood plasma, or the liquid portion of blood. There are a number of dissolved particles in the blood plasma, but the major ones are glucose, sodium, and blood urea nitrogen, and a normal osmolality is between 285 and 295 milliOsmoles per kilogram.

Now, during periods of dehydration there is an increase in concentration of these particles in the blood and osmolality increases. The osmoreceptors in the hypothalamus sense the change in osmolality and this triggers the sensation of thirst. The water that we drink gets absorbed and dilutes the blood, bringing the osmolality back to normal.

In addition to osmoreceptors, the hypothalamus also contains the supraoptic and paraventricular nuclei that produce antidiuretic hormone, or ADH, which is then sent to the posterior pituitary for storage. ADH is also called vasopressin because it causes smooth muscle around the blood vessels to contract, which increases resistance and raises blood pressure.

When the osmoreceptors detect high osmolality, they signal the supraoptic nucleus to send ADH into the blood which travels to the kidneys, specifically to the principal cells in the distal convoluted tubule, and collecting ducts, of the nephrons. Here ADH binds to a receptor called vasopressin receptor 2, or VR2. This causes aquaporin proteins inside the principal cells to embed into the cell membrane and open a channel that only lets water from the lumen of the nephron back into the blood. Just like drinking more water, this dilutes the blood, and returns plasma osmolality to a normal level. However, this reabsorption process also decides how much water leaves the body as urine, and how concentrated the urine is, which is one of the things that keeps a normal urine osmolality between 300 and 900 milliOsmoles per kilogram.

Now that we know all this, diabetes insipidus is when the kidneys reabsorb too little water, so the water remains in the nephrons and is lost via urine. This leads to a lot of dilute urine, or polyuria. Since there’s less water in the blood, plasma osmolality increases and that triggers thirst and polydipsia. Now, if the problem is caused by a lack of ADH, it’s called central diabetes insipidus. If it’s due to a decreased response to ADH by the kidneys, it’s called nephrogenic diabetes.

Let’s start with central diabetes insipidus, which can be caused by conditions that affect the hypothalamus, in which case it won’t be able to produce ADH, or conditions that affect the pituitary gland, in which case there’s no place to store the ADH, and in some cases, both the hypothalamus and the pituitary gland are affected. As a result, there’s insufficient ADH in the blood, and that means there is less vasoconstriction, and insufficient aquaporins in the distal convoluted tubule and collecting duct. Some causes of central diabetes insipidus include pituitary tumors, head trauma, head surgery, ischemic encephalopathy, autoimmune conditions or sometimes, the cause can be idiopathic.

Then there’s nephrogenic diabetes insipidus, which is when there’s a problem with the kidneys themselves, which makes them unresponsive to ADH. A high yield fact is that this is often due to a hereditary genetic defect of the vasopressin receptors or aquaporin proteins. Both of these lead to nephrons that are unresponsive to ADH. In addition, there are medications like lithium that can decrease the production of aquaporin proteins in the collecting duct. Sometimes, nephrogenic diabetes insipidus can be caused by hypokalemia. That’s because the aquaporins can degrade in the early phases of hypokalemia. Sometimes nephrogenic diabetes can also be secondary to hypercalcemia, through an unclear mechanism. Finally, demeclocycline, which is an ADH antagonist, can block the vasopressin receptors, leading to nephrogenic diabetes insipidus.

Now, the symptoms of both central and nephrogenic diabetes insipidus are polyuria and polydipsia and you have to remember this for your tests. A person with diabetes insipidus typically produces over 3 liters of dilute urine each day, so it can quickly lead to dehydration and hypotension. The increase in plasma osmolality can result in fatigue, nausea, poor concentration, or confusion.

The diagnosis of diabetes insipidus starts with a blood osmolality test, which would show an increased blood osmolality of above 290 milliosmoles per kilogram in both central and nephrogenic diabetes insipidus. The urine specific gravity is lower than 1006, meaning the kidneys aren’t able to properly concentrate urine. There’s also hyperosmotic volume contraction This means that there’s decreased extracellular fluid in the body, and the remaining fluid is hyperosmotic since the water is lost, but the solutes remain. Okay, the way to differentiate central and nephrogenic diabetes insipidus is to look at the ADH level; with central diabetes insipidus, there’s low ADH, while with nephrogenic diabetes insipidus, ADH is normal or high. Remember this as it’s a very high yield concept.

In addition, a water deprivation test can be done to distinguish diabetes insipidus from psychogenic polydipsia, which is when an individual drinks more water than they need, because of a variety of psychological or psychiatric causes. That’s where an individual doesn’t drink water for 2 to 3 hours, then hourly measurements of urine volume and osmolality are done. In a person with diabetes insipidus, urine osmolality will normally stay below 300 mOsm/kg despite having no fluid intake. With psychogenic polydipsia, urine osmolality increases during the test.

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  3. "undefined" Reviews in Endocrine and Metabolic Disorders (2003)
  4. "Treatment of Lithium-Induced Diabetes Insipidus with Amiloride" Pharmacotherapy (2003)
  5. "Paraneoplastic Syndromes: An Approach to Diagnosis and Treatment" Mayo Clinic Proceedings (2010)
  6. "Syndrome of Inappropriate Antidiuretic Hormone Secretion Induced by a Single Dose of Oral Cyclophosphamide" Annals of Pharmacotherapy (2012)